Citadel Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.4K | Buy |
+6,866
| New | +$36.4K | ﹤0.01% | 5536 |
|
|
2025
Q1 | – | Sell |
-2,029
| Closed | -$14.2K | – | 6997 |
|
|
2024
Q4 | $14.2K | Buy |
+2,029
| New | +$14.2K | ﹤0.01% | 5690 |
|
|
2024
Q3 | – | Sell |
-2,278
| Closed | -$166K | – | 6778 |
|
|
2024
Q2 | $166K | Buy |
+2,278
| New | +$166K | ﹤0.01% | 4739 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6868 |
|
|
2023
Q4 | – | Sell |
-1,758
| Closed | -$68.3K | – | 6728 |
|
|
2023
Q3 | $68.3K | Sell |
1,758
-7,075
| -80% | -$275K | ﹤0.01% | 4972 |
|
|
2023
Q2 | $510K | Buy |
8,833
+5,336
| +153% | +$308K | ﹤0.01% | 3625 |
|
|
2023
Q1 | $227K | Sell |
3,497
-3,748
| -52% | -$244K | ﹤0.01% | 4527 |
|
|
2022
Q4 | $199K | Sell |
7,245
-100
| -1% | -$2.75K | ﹤0.01% | 4706 |
|
|
2022
Q3 | $215K | Buy |
7,345
+3,194
| +77% | +$93.5K | ﹤0.01% | 4813 |
|
|
2022
Q2 | $80K | Buy |
4,151
+1,187
| +40% | +$22.9K | ﹤0.01% | 5370 |
|
|
2022
Q1 | $240K | Buy |
+2,964
| New | +$240K | ﹤0.01% | 5149 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7252 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7152 |
|